1. Neville BW, Damm DD, Allen CM, Chi AC. Oral and maxillofacial pathology. 4th ed. St. Louis: Elsevier; 2016. p. 422–72.
2. Fonseca I, Assaad A, Katabi N, Seethala R, Weinreb I, Wenig BM. Polymorphous adenocarcinoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takashi T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: International Agency for Research on Cancer; 2017. p. 167–8.
3. Chi AC, Neville BW. Surface papillary epithelial hyperplasia (rough mucosa) is a helpful clue for identification of polymorphous low-grade adenocarcinoma. Head Neck Pathol. 2015;9:244–52.
4. Rooper L, Sharma R, Bishop JA. Polymorphous low grade adenocarcinoma has a consistent p63+/p40− immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma. Head Neck Pathol. 2015;9:79–84.
5. Persson F, Fehr A, Sundelin K, Schulte B, Lon̈ing T, Stenman G. Studies of genomic imbalances and the MYB-NFIB gene fusion in polymorphous low-grade adenocarcinoma of the head and neck. Int J Oncol. 2012;40:80–4.